This review discusses important and clinically relevant outcomes that future trials should be powered to address and identifies the challenges facing the neonatal clinical trials community.
Future trials should consider including quantitative tests of sensory function, developed recently, which can identify small changes around the site of injury in complete thoracic injuries although these need further validation for general application (Savic et al., 2006, 2007).
Thus, future trials should test the potential clinical advantages of continuous infusion in this patient population.
Future trials should probably focus on that specific high-risk population [69].
Future trials should overcome the limitations of the currently available evidence.
Future trials should include a screening procedure to evaluate KIT expression in SCLC samples.
Future trials should include these important outcomes.
Future trials should evaluate this aspect in a prospective cohort.
Future trials should avoid the shortcomings described in this article.
Future trials should be conducted in a more representative population.
